DRTSW
Income statement / Annual
Last year (2024), Alpha Tau Medical Ltd.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Alpha Tau Medical Ltd.'s net income was -$31.75 M.
See Alpha Tau Medical Ltd.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$1.10 M
|
$1.07 M
|
$979,000.00
|
$776,000.00
|
$86,000.00
|
$0.00
|
| Gross Profit |
-$1.10 M
|
-$1.07 M
|
-$979,000.00
|
-$776,000.00
|
-$86,000.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$27.02 M
|
$26.42 M
|
$20.89 M
|
$11.45 M
|
$7.54 M
|
$6.64 M
|
| General & Administrative Expenses |
$0.00
|
$7.33 M
|
$10.27 M
|
$1.86 M
|
$1.41 M
|
$977,000.00
|
| Selling & Marketing Expenses |
$0.00
|
$1.92 M
|
$974,000.00
|
$482,000.00
|
$288,000.00
|
$397,000.00
|
| Selling, General & Administrative Expenses |
$7.92 M
|
$9.26 M
|
$11.25 M
|
$2.34 M
|
$1.70 M
|
$1.37 M
|
| Other Expenses |
$0.00
|
-$72.20 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$34.94 M
|
-$35.68 M
|
$32.14 M
|
$13.79 M
|
$9.24 M
|
$8.01 M
|
| Cost And Expenses |
-$36.04 M
|
-$35.68 M
|
$32.14 M
|
$13.79 M
|
$9.24 M
|
$8.01 M
|
| Interest Income |
$4.28 M
|
$4.76 M
|
$1.79 M
|
$211,000.00
|
$613,000.00
|
$776,000.00
|
| Interest Expense |
$344,000.00
|
$39,000.00
|
$1.77 M
|
$13.27 M
|
$217,000.00
|
$0.00
|
| Depreciation & Amortization |
$1.10 M
|
$1.07 M
|
$979,000.00
|
$776,000.00
|
$86,000.00
|
$66,000.00
|
| EBITDA |
-$30.30 M |
-$28.03 M |
-$32.74 M |
-$13.22 M |
-$9.16 M |
-$7.94 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$4.30 M
|
-$64.82 M
|
-$1.61 M
|
-$13.47 M
|
$520,000.00
|
-$308,000.00
|
| Income Before Tax |
-$31.74 M
|
-$29.14 M
|
-$33.74 M
|
-$27.26 M
|
-$8.72 M
|
-$8.32 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$6,000.00
|
$16,000.00
|
$20,000.00
|
$7,000.00
|
$158,000.00
|
$146,000.00
|
| Net Income |
-$31.75 M
|
-$29.16 M
|
-$33.76 M
|
-$27.27 M
|
-$8.88 M
|
-$8.46 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.45 |
-0.42 |
-0.53 |
-0.67 |
-0.22 |
-0.13 |
| EPS Diluted |
-0.45 |
-0.42 |
-0.53 |
-0.67 |
-0.22 |
-0.13 |
| Weighted Average Shares Out |
$69.93 M
|
$69.38 M
|
$63.53 M
|
$40.53 M
|
$40.43 M
|
$67.62 M
|
| Weighted Average Shares Out Diluted |
$69.93 M
|
$69.38 M
|
$63.53 M
|
$40.53 M
|
$40.43 M
|
$67.62 M
|
| Link |
|
|
|
|
|
|
